u/Busy_Negotiation_681

Hey everyone, I’ve been investing in Abcellera for the past two months. I find their leadership, technology platform, and the high-profile investors on their cap table highly compelling

With the company's recent shift toward its internal pipeline, I’m curious to hear your thoughts on how ABCL635 will find its place in the massive menopause market (estimated at a 20–30B TAM)

Right now, the landscape is heavily dominated by Hormone Replacement Therapies or HRTs in short

HRTs are significantly cheaper, widely adopted, and offer systemic benefits beyond just treating hot flashes.

Given that, how do you see ABCL635 competing? Would love to hear your thoughts